Literature DB >> 30728259

Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route.

Cyrille Mathieu1,2,3, Marion Ferren4,2,3, Eric Jurgens4,2, Claire Dumont3, Ksenia Rybkina4,2, Olivia Harder5, Debora Stelitano4,2, Silvia Madeddu4,2,6, Giuseppina Sanna4,2,6, Dayna Schwartz4,2, Sudipta Biswas4,2, Diana Hardie7, Takao Hashiguchi8, Anne Moscona4,2,9,10, Branka Horvat3, Stefan Niewiesk5, Matteo Porotto1,2,11.   

Abstract

A clinical isolate of measles virus (MeV) bearing a single amino acid alteration in the viral fusion protein (F; L454W) was previously identified in two patients with lethal sequelae of MeV central nervous system (CNS) infection. The mutation dysregulated the viral fusion machinery so that the mutated F protein mediated cell fusion in the absence of known MeV cellular receptors. While this virus could feasibly have arisen via intrahost evolution of the wild-type (wt) virus, it was recently shown that the same mutation emerged under the selective pressure of small-molecule antiviral treatment. Under these conditions, a potentially neuropathogenic variant emerged outside the CNS. While CNS adaptation of MeV was thought to generate viruses that are less fit for interhost spread, we show that two animal models can be readily infected with CNS-adapted MeV via the respiratory route. Despite bearing a fusion protein that is less stable at 37°C than the wt MeV F, this virus infects and replicates in cotton rat lung tissue more efficiently than the wt virus and is lethal in a suckling mouse model of MeV encephalitis even with a lower inoculum. Thus, either during lethal MeV CNS infection or during antiviral treatment in vitro, neuropathogenic MeV can emerge, can infect new hosts via the respiratory route, and is more pathogenic (at least in these animal models) than wt MeV.IMPORTANCE Measles virus (MeV) infection can be severe in immunocompromised individuals and lead to complications, including measles inclusion body encephalitis (MIBE). In some cases, MeV persistence and subacute sclerosing panencephalitis (SSPE) occur even in the face of an intact immune response. While they are relatively rare complications of MeV infection, MIBE and SSPE are lethal. This work addresses the hypothesis that despite a dysregulated viral fusion complex, central nervous system (CNS)-adapted measles virus can spread outside the CNS within an infected host.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  central nervous system infections; in vivo infection; pathogenesis; viral fusion

Mesh:

Substances:

Year:  2019        PMID: 30728259      PMCID: PMC6450100          DOI: 10.1128/JVI.01862-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Nonpeptide inhibitors of measles virus entry.

Authors:  Aiming Sun; Andrew Prussia; Weiqiang Zhan; Ernest E Murray; Joshua Doyle; Li-Ting Cheng; Jeong-Joong Yoon; Eugene V Radchenko; Vladimir A Palyulin; Richard W Compans; Dennis C Liotta; Richard K Plemper; James P Snyder
Journal:  J Med Chem       Date:  2006-08-24       Impact factor: 7.446

2.  Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus.

Authors:  A Schmid; P Spielhofer; R Cattaneo; K Baczko; V ter Meulen; M A Billeter
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

3.  Structures of the prefusion form of measles virus fusion protein in complex with inhibitors.

Authors:  Takao Hashiguchi; Yoshinari Fukuda; Rei Matsuoka; Daisuke Kuroda; Marie Kubota; Yuta Shirogane; Shumpei Watanabe; Kouhei Tsumoto; Daisuke Kohda; Richard Karl Plemper; Yusuke Yanagi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

4.  Nectin-4 Interactions Govern Measles Virus Virulence in a New Model of Pathogenesis, the Squirrel Monkey (Saimiri sciureus).

Authors:  Sébastien Delpeut; Bevan Sawatsky; Xiao-Xiang Wong; Marie Frenzke; Roberto Cattaneo; Veronika von Messling
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

Review 5.  Measles.

Authors:  William J Moss; Diane E Griffin
Journal:  Lancet       Date:  2011-08-17       Impact factor: 79.321

6.  Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters.

Authors:  Shumpei Watanabe; Yuta Shirogane; Satoshi O Suzuki; Satoshi Ikegame; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

7.  Effective ribavirin concentration in mice brain using cyclodextrin as a drug carrier: evaluation in a measles encephalitis model.

Authors:  H Jeulin; V Venard; D Carapito; C Finance; F Kedzierewicz
Journal:  Antiviral Res       Date:  2009-01-06       Impact factor: 5.970

8.  Fatal measles virus infection prevented by brain-penetrant fusion inhibitors.

Authors:  Jeremy C Welsch; Aparna Talekar; Cyrille Mathieu; Antonello Pessi; Anne Moscona; Branka Horvat; Matteo Porotto
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

9.  Rescue of measles viruses from cloned DNA.

Authors:  F Radecke; P Spielhofer; H Schneider; K Kaelin; M Huber; C Dötsch; G Christiansen; M A Billeter
Journal:  EMBO J       Date:  1995-12-01       Impact factor: 11.598

10.  Early target cells of measles virus after aerosol infection of non-human primates.

Authors:  Ken Lemon; Rory D de Vries; Annelies W Mesman; Stephen McQuaid; Geert van Amerongen; Selma Yüksel; Martin Ludlow; Linda J Rennick; Thijs Kuiken; Bertus K Rima; Teunis B H Geijtenbeek; Albert D M E Osterhaus; W Paul Duprex; Rik L de Swart
Journal:  PLoS Pathog       Date:  2011-01-27       Impact factor: 6.823

View more
  10 in total

Review 1.  Measles Resurgence and Drug Development.

Authors:  Richard K Plemper
Journal:  Curr Opin Virol       Date:  2020-04-01       Impact factor: 7.090

Review 2.  Measles Encephalitis: Towards New Therapeutics.

Authors:  Marion Ferren; Branka Horvat; Cyrille Mathieu
Journal:  Viruses       Date:  2019-11-02       Impact factor: 5.048

3.  Mutated Measles Virus Matrix and Fusion Protein Influence Viral Titer In Vitro and Neuro-Invasion in Lewis Rat Brain Slice Cultures.

Authors:  Johannes Busch; Soroth Chey; Michael Sieg; Thomas W Vahlenkamp; Uwe G Liebert
Journal:  Viruses       Date:  2021-04-01       Impact factor: 5.048

4.  Comparable Infection Level and Tropism of Measles Virus and Canine Distemper Virus in Organotypic Brain Slice Cultures Obtained from Natural Host Species.

Authors:  Brigitta M Laksono; Diana N Tran; Ivanela Kondova; Harry G H van Engelen; Samira Michels; Sham Nambulli; Rory D de Vries; W Paul Duprex; Georges M G M Verjans; Rik L de Swart
Journal:  Viruses       Date:  2021-08-10       Impact factor: 5.048

Review 5.  Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds.

Authors:  Katharina S Schmitz; Mona V Lange; Lennert Gommers; Kim Handrejk; Danielle P Porter; Christopher A Alabi; Anne Moscona; Matteo Porotto; Rory D de Vries; Rik L de Swart
Journal:  Viruses       Date:  2022-05-29       Impact factor: 5.818

Review 6.  Multiple Receptors Involved in Invasion and Neuropathogenicity of Canine Distemper Virus: A Review.

Authors:  Jianjun Zhao; Yanrong Ren
Journal:  Viruses       Date:  2022-07-12       Impact factor: 5.818

7.  Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain.

Authors:  Cyrille Mathieu; Francesca T Bovier; Marion Ferren; Nicole A P Lieberman; Camilla Predella; Alexandre Lalande; Vikas Peddu; Michelle J Lin; Amin Addetia; Achchhe Patel; Victor Outlaw; Barbara Corneo; N Valerio Dorrello; Thomas Briese; Diana Hardie; Branka Horvat; Anne Moscona; Alexander L Greninger; Matteo Porotto
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

8.  Inhibition of Measles Viral Fusion Is Enhanced by Targeting Multiple Domains of the Fusion Protein.

Authors:  Francesca T Bovier; Ksenia Rybkina; Sudipta Biswas; Olivia Harder; Tara C Marcink; Stefan Niewiesk; Anne Moscona; Christopher A Alabi; Matteo Porotto
Journal:  ACS Nano       Date:  2021-07-22       Impact factor: 18.027

9.  Hijacking the Fusion Complex of Human Parainfluenza Virus as an Antiviral Strategy.

Authors:  T C Marcink; E Yariv; K Rybkina; V Más; F T Bovier; A des Georges; A L Greninger; C A Alabi; M Porotto; N Ben-Tal; A Moscona
Journal:  mBio       Date:  2020-02-11       Impact factor: 7.867

10.  Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain.

Authors:  Victor K Outlaw; Francesca T Bovier; Megan C Mears; Maria N Cajimat; Yun Zhu; Michelle J Lin; Amin Addetia; Nicole A P Lieberman; Vikas Peddu; Xuping Xie; Pei-Yong Shi; Alexander L Greninger; Samuel H Gellman; Dennis A Bente; Anne Moscona; Matteo Porotto
Journal:  mBio       Date:  2020-10-20       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.